Table of Content

Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary

Chapter 2 Market Overview
Prenatal Testing
History of Prenatal Testing
Most Common Chromosomal Abnormalities
Down Syndrome
Trisomy 13 and Trisomy 18
Sex Chromosome Differences
Neural Tube Defects
Noninvasive Techniques
Noninvasive Prenatal Test/Cell-Free DNA Screening
Maternal Serum Screening Test
Ultrasound Testing
Others
Invasive Techniques
Chorionic Villus Sampling
Amniocentesis

Chapter 3 Market Dynamics
Factors Affecting the Prenatal Testing Market
Market Drivers
Increase in Down Syndrome
Increase in Rare Genetic Disorders
Increasing Maternal Age
Advancements in Technology
Restraints
High Cost of Testing
False Positives and Negatives Results
Future Opportunities
Expanding Applications
Emerging Markets
Personalized Medicine
Challenges
Regulatory Hurdles
Public Perception
Noninvasive Prenatal Testing Coverage Challenges: Policy Disparities

Chapter 4 Emerging and Upcoming Technologies in the Market
Introduction
Enhancing Copy Number Variation Detection Through Whole-Genome Sequencing
Single Nucleotide Polymorphisms Analysis
Whole-Exome Sequencing
Advanced Imaging Techniques
Liquid Biopsy for Cancer Detection
Artificial Intelligence in Prenatal Testing

Chapter 5 Market Segmentation Analysis
Segmentation by Product Type
Market Size
Consumables
Instruments
Segmentation by Technology
Overview
Market Share
Noninvasive Techniques
Invasive Techniques
Segmentation by Application
Overview
Market Share
Neural Tube Defects
Down Syndrome
Rare Genetic Disorders
Others
Segmentation by End User
Overview
Market Share
Diagnostic Laboratories
Hospitals
Geographic Breakdown
Overview
North America
Europe
Asia-Pacific
Rest of the World

Chapter 6 Competitive Landscape
Mergers, Acquisitions and Collaborations
Prenatal Testing Manufacturers and Service Providers Market Shares
Patent Review and New Developments
Overview
Patent Analysis by Year

Chapter 7 ESG Development
Introduction
Sustainability of Prenatal Testing in Industry

Chapter 8 Appendix
Methodology
Intended Audience
Abbreviations
Sources
Company Profiles
10X GENOMICS
AGILENT TECHNOLOGIES INC.
BGI
EUROFINS SCIENTIFIC
F. HOFFMANN-LA ROCHE LTD.
ILLUMINA INC.
LABORATORY CORPORATION OF AMERICA HOLDINGS
MEDICOVER GENETICS
NATERA INC.
QIAGEN
QUEST DIAGNOSTICS INC.
REVVITY INC.
THERMO FISHER SCIENTIFIC INC.
YOURGENE HEALTH



List of Figures

Summary Figure : Global Prenatal Testing Market, by Product, 2020-2028
Figure 1 : Down Syndrome Karyotype
Figure 2 : Market Dynamics: Global Prenatal Testing Market
Figure 3 : Universal NIPT Coverage Across Payer Networks, 2020
Figure 4 : Global Prenatal Testing Market, by Segment Analysis
Figure 5 : Global Prenatal Testing Market, by Product, 2020-2028
Figure 6 : Global Consumables Products Market in Prenatal Testing, by Region, 2020-2028
Figure 7 : Global Instruments Products Market in Prenatal Testing, by Region, 2020-2028
Figure 8 : Global Prenatal Testing Market, by Technology, 2020-2028
Figure 9 : Global Noninvasive Techniques Market in Prenatal Testing, by Type, 2020-2028
Figure 10 : Global Noninvasive Prenatal Testing Market, by Region, 2020-2028
Figure 11 : Global Maternal Serum Screening Market, by Region, 2020-2028
Figure 12 : Global Ultrasound-Based Testing Market, by Region, 2020-2028
Figure 13 : Global Others Noninvasive Techniques Market, by Region, 2020-2028
Figure 14 : Global Invasive Techniques in Prenatal Testing Market, by Type, 2020-2028
Figure 15 : Global Amniocentesis Invasive Techniques Market, by Region, 2020-2028
Figure 16 : Global Chorionic Villus Sampling Invasive Techniques Market, by Region, 2020-2028
Figure 17 : Global Others Invasive Techniques Market, by Region, 2020-2028
Figure 18 : Global Prenatal Testing Market, by Application, 2020-2028
Figure 19 : Global Neural Tube Defects Market in Prenatal Testing, by Region, 2020-2028
Figure 20 : Global Down Syndrome Market in Prenatal Testing, by Region, 2020-2028
Figure 21 : Global Rare Genetic Disorders Market in Prenatal Testing, by Region, 2020-2028
Figure 22 : Global Other Application Market in Prenatal Testing, by Region, 2020-2028
Figure 23 : Global Prenatal Testing Market, by End User, 2020-2028
Figure 24 : Global Prenatal Testing Market in Diagnostic Laboratories, by Region, 2020-2028
Figure 25 : Global Prenatal Testing Market, in Hospitals, by Region, 2020-2028
Figure 26 : Global Prenatal Testing Market, by Region, 2020-2028
Figure 27 : Global Prenatal Testing Market Share, by Region, 2022
Figure 28 : North American Prenatal Testing Market, by Country, 2020-2028
Figure 29 : European Prenatal Testing Market, by Country, 2020-2028
Figure 30 : Asia-Pacific Prenatal Testing Market, by Country, 2020-2028
Figure 31 : Global Prenatal Testing Market Shares, by Key Manufacturers and Service Providers 2022
Figure 32 : Published Patent Share, by Country, 2020-2023
Figure 33 : Business Benefits of a Strong ESG Proposition
Figure 34 : ESG-Adoption Level Across All the Industries, 2021 and 2022
Figure 35 : 10 Business Sustainability Trends Identified for 2023
Figure 36 : 10X Genomics: Revenue Share, by Business Unit, FY 2023
Figure 37 : 10X Genomics: Revenue Share, by Country/Region, FY 2023
Figure 38 : Agilent Technologies Inc.: Revenue Share, by Business Unit, FY 2023
Figure 39 : Agilent Technologies Inc.: Revenue Share, by Country/Region, FY 2023
Figure 40 : Eurofins Scientific: Revenue Share, by Country/Region, FY 2023
Figure 41 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 42 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Country/Region, FY 2023
Figure 43 : Illumina Inc.: Revenue Share, by Business Unit, FY 2022
Figure 44 : Illumina Inc.: Revenue Share, by Country/Region, FY 2023
Figure 45 : Laboratory Corporation of America Holdings: Revenue Share, by Business Unit, FY 2023
Figure 46 : Laboratory Corporation of America Holdings: Revenue Share, by Country/Region, FY 2023
Figure 47 : Natera Inc.: Revenue Share, by Business Unit, FY 2022
Figure 48 : Natera Inc.: Revenue Share, by Country/Region, FY 2022
Figure 49 : Qiagen: Revenue Share, by Business Unit, 2022
Figure 50 : Qiagen: Revenue Share, by Region, 2022
Figure 51 : Quest Diagnostic Inc.: Revenue Share, by Business Unit, FY 2023
Figure 52 : Revvity Inc.: Revenue Share, by Business Unit, FY 2022
Figure 53 : Revvity Inc.: Revenue Share, by Country/Region, FY 2022
Figure 54 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, 2022
Figure 55 : Thermo Fisher Scientific Inc.: Revenue Share, by Region, 2022

List of Tables


Summary Table : Global Prenatal Testing Market, by Product, Through 2028
Table 1 : Timeline of Technology Development of Prenatal Testing, 1956–2017
Table 2 : Chance for Down Syndrome, by Age
Table 3 : Price Per Prenatal Testing Strategy, 2021
Table 4 : Global Prenatal Testing Market, by Product, Through 2028
Table 5 : Global Consumables Products Market in Prenatal Testing, by Region, Through 2028
Table 6 : Global Instruments Products Market in Prenatal Testing, by Region, Through 2028
Table 7 : Global Prenatal Testing Market, by Technology, Through 2028
Table 8 : Global Noninvasive Techniques Market in Prenatal Testing, by Type, Through 2028
Table 9 : Global Noninvasive Prenatal Testing Market, by Region, Through 2028
Table 10 : Global Maternal Serum Screening Market, by Region, Through 2028
Table 11 : Global Ultrasound-Based Testing Market, by Region, Through 2028
Table 12 : Global Others Noninvasive Techniques Market, by Region, Through 2028
Table 13 : Global Invasive Techniques in Prenatal Testing Market, by Type, Through 2028
Table 14 : Global Amniocentesis Invasive Techniques Market, by Region, Through 2028
Table 15 : Global Chorionic Villus Sampling Invasive Techniques Market, by Region, Through 2028
Table 16 : Global Others Invasive Techniques Market, by Region, Through 2028
Table 17 : Global Prenatal Testing Market, by Application, Through 2028
Table 18 : Global Neural Tube Defects Market in Prenatal Testing, by Region, Through 2028
Table 19 : Global Down Syndrome Market in Prenatal Testing, by Region, Through 2028
Table 20 : Global Rare Genetic Disorders Market in Prenatal Testing, by Region, Through 2028
Table 21 : Global Other Application Market in Prenatal Testing, by Region, Through 2028
Table 22 : Global Prenatal Testing Market, by End User, Through 2028
Table 23 : Global Prenatal Testing Market in Diagnostic Laboratories, by Region, Through 2028
Table 24 : Global Prenatal Testing Market in Hospitals, by Region, Through 2028
Table 25 : Global Prenatal Testing Market, by Region, Through 2028
Table 26 : North American Prenatal Testing Market, by Country, Through 2028
Table 27 : European Prenatal Testing Market, by Country, Through 2028
Table 28 : Asia-Pacific Prenatal Testing Market, by Country, Through 2028
Table 29 : Mergers and Acquisitions: Prenatal Testing Manufacturers and Service Providers
Table 30 : Patent Analysis, by Year, 2020–August 2023
Table 31 : Major Patents in Prenatal Testing, by Applicant, 2023–February 2024
Table 32 : ESG Highlights, by Major Players, 2022
Table 33 : ESG Rankings of Major Companies Manufacturing Prenatal Testing, 2023
Table 34 : Abbreviations
Table 35 : Report Sources
Table 36 : 10X Genomics: Company Snapshot
Table 37 : 10X Genomics: Financial Performance, FY 2022 and 2023
Table 38 : 10X Genomics: Product Portfolio
Table 39 : 10X Genomics: News and Key Developments, 2023
Table 40 : Agilent Technologies Inc.: Company Snapshot
Table 41 : Agilent Technologies Inc.: Financial Performance, FY 2022 and 2023
Table 42 : Agilent Technologies Inc.: Product Portfolio
Table 43 : Agilent Technologies Inc.: News and Key Developments, 2020-2023
Table 44 : BGI: Company Snapshot
Table 45 : BGI Genomics: Product Portfolio
Table 46 : BGI Genomics: News and Key Developments, 2023 and 2024
Table 47 : Eurofins Scientific: Company Snapshot
Table 48 : Eurofins Scientific: Financial Performance, FY 2022 and 2023
Table 49 : Eurofins Scientific: Product Portfolio
Table 50 : Eurofins Scientific: News and Key Developments, 2022
Table 51 : F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 52 : F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2022 and 2023
Table 53 : F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 54 : F. Hoffmann-La Roche Ltd.: News and Key Developments, 2022 and 2023
Table 55 : Illumina Inc.: Company Snapshot
Table 56 : Illumina Inc.: Financial Performance, FY 2022 and 2023
Table 57 : Illumina Inc.: Product Portfolio
Table 58 : Illumina Inc.: News and Key Developments, 2022-2024
Table 59 : Laboratory Corporation of America Holdings: Company Snapshot
Table 60 : Laboratory Corporation of America Holdings: Financial Performance, FY 2022 and 2023
Table 61 : Laboratory Corporation of America Holdings: Product Portfolio
Table 62 : Laboratory Corporation of America Holdings: News and Key Developments, 2022-2024
Table 63 : Medicover Genetics: Company Snapshot
Table 64 : Medicover Genetics: Product Portfolio
Table 65 : Medicover Genetics: News and Key Developments, 2022 and 2023
Table 66 : Natera Inc.: Company Snapshot
Table 67 : Natera Inc.: Financial Performance, FY 2021 and 2022
Table 68 : Natera Inc.: Product Portfolio
Table 69 : Natera Inc.: News and Key Developments, 2024
Table 70 : Qiagen: Company Snapshot
Table 71 : QIAGEN: Annual Financials/Revenue, 2021 and 2022
Table 72 : Qiagen: Product Portfolio
Table 73 : Qiagen: News and Key Developments, 2022-2024
Table 74 : Quest Diagnostic Inc.: Company Snapshot
Table 75 : Quest Diagnostic Inc.: Financial Performance, FY 2022 and 2023
Table 76 : Quest Diagnostic Inc.: Product Portfolio
Table 77 : Quest Diagnostic Inc.: News and Key Developments, 2021–2024
Table 78 : Revvity Inc.: Company Snapshot
Table 79 : Revvity Inc.: Financial Performance, FY 2021 and 2022
Table 80 : Revvity Inc.: Product Portfolio
Table 81 : Revvity Inc.: News and Key Developments, 2021–2023
Table 82 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 83 : Thermo Fisher Scientific Inc.: Annual Financials/Revenue, 2021 and 2022
Table 84 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 85 : Thermo Fisher Scientific Inc.: News and Key Developments, 2022 and 2023
Table 86 : Yourgene Health: Company Snapshot
Table 87 : Yourgene Health Product Portfolio
Table 88 : Yourgene Health News/Key Developments, 2022 and 2023